Treatment failure in intracranial primary germinomas. 2007

Kyu-Won Shim, and Tae-Gon Kim, and Chang-Ok Suh, and Jae-Ho Cho, and Chul-Joo Yoo, and Joong-Uhn Choi, and Jung-Hee Kim, and Dong-Seok Kim
Department of Neurosurgery, Brain Korea 21 Project for Medical Science, Brain Research Institute, Yonsei University College of Medicine, Seoul, South Korea.

OBJECTIVE A radiation dose of 40-50 Gy is able to produce a cure rate of more than 90% in intracranial pure germinoma. However, many attempts have been made to reduce the dose and volume of radiation without compromising the disease control rate because of the toxicity of irradiation. This retrospective study is intended to provide the physician with an appropriate therapeutic strategy. METHODS We reviewed a series of 10 recurrent germinomas among 117 germinomas diagnosed histologically or clinically between 1979 and 2002. These patients involved underwent three different treatment modalities; radiation alone (N = 71), chemotherapy alone (N = 9), and combined therapy (N = 37). The 10-year overall and relapse-free survival rates were 97 and 93% in the radiation alone group, 89 and 67% in the chemotherapy alone group, and 92 and 92% in the combined therapy group, respectively. As expected, both radiation therapy and combined therapy were effective in controlling the disease. Tumor recurrence was closely related to the volume of radiation but not to the dose of radiation. If the tumor bed and craniospinal axis were fully covered, the radiation dose might be reduced. Chemotherapy alone showed earlier recurrence and a higher tumor recurrence rate. In the case of combined therapy, chemotherapy was useful in reducing the radiation dose but revealed some toxicity (death of two patients). CONCLUSIONS The investigation of a possible further dose reduction seems worthwhile. Radiation therapy alone with a dose of less than 40 Gy should be compared with ongoing chemotherapeutic protocols combined with low-dose irradiation.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004307 Dose-Response Relationship, Radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. Dose Response Relationship, Radiation,Dose-Response Relationships, Radiation,Radiation Dose-Response Relationship,Radiation Dose-Response Relationships,Relationship, Radiation Dose-Response,Relationships, Radiation Dose-Response

Related Publications

Kyu-Won Shim, and Tae-Gon Kim, and Chang-Ok Suh, and Jae-Ho Cho, and Chul-Joo Yoo, and Joong-Uhn Choi, and Jung-Hee Kim, and Dong-Seok Kim
September 1987, Neurologia medico-chirurgica,
Kyu-Won Shim, and Tae-Gon Kim, and Chang-Ok Suh, and Jae-Ho Cho, and Chul-Joo Yoo, and Joong-Uhn Choi, and Jung-Hee Kim, and Dong-Seok Kim
July 1993, Zhonghua wai ke za zhi [Chinese journal of surgery],
Kyu-Won Shim, and Tae-Gon Kim, and Chang-Ok Suh, and Jae-Ho Cho, and Chul-Joo Yoo, and Joong-Uhn Choi, and Jung-Hee Kim, and Dong-Seok Kim
March 1979, Surgical neurology,
Kyu-Won Shim, and Tae-Gon Kim, and Chang-Ok Suh, and Jae-Ho Cho, and Chul-Joo Yoo, and Joong-Uhn Choi, and Jung-Hee Kim, and Dong-Seok Kim
January 2018, Turkish neurosurgery,
Kyu-Won Shim, and Tae-Gon Kim, and Chang-Ok Suh, and Jae-Ho Cho, and Chul-Joo Yoo, and Joong-Uhn Choi, and Jung-Hee Kim, and Dong-Seok Kim
January 1989, Journal of neurosurgery,
Kyu-Won Shim, and Tae-Gon Kim, and Chang-Ok Suh, and Jae-Ho Cho, and Chul-Joo Yoo, and Joong-Uhn Choi, and Jung-Hee Kim, and Dong-Seok Kim
February 1987, Ugeskrift for laeger,
Kyu-Won Shim, and Tae-Gon Kim, and Chang-Ok Suh, and Jae-Ho Cho, and Chul-Joo Yoo, and Joong-Uhn Choi, and Jung-Hee Kim, and Dong-Seok Kim
January 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
Kyu-Won Shim, and Tae-Gon Kim, and Chang-Ok Suh, and Jae-Ho Cho, and Chul-Joo Yoo, and Joong-Uhn Choi, and Jung-Hee Kim, and Dong-Seok Kim
May 1991, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
Kyu-Won Shim, and Tae-Gon Kim, and Chang-Ok Suh, and Jae-Ho Cho, and Chul-Joo Yoo, and Joong-Uhn Choi, and Jung-Hee Kim, and Dong-Seok Kim
October 2017, Pediatric blood & cancer,
Kyu-Won Shim, and Tae-Gon Kim, and Chang-Ok Suh, and Jae-Ho Cho, and Chul-Joo Yoo, and Joong-Uhn Choi, and Jung-Hee Kim, and Dong-Seok Kim
August 1997, Journal of neurosurgery,
Copied contents to your clipboard!